| | | 56676 | | 04.03.2004 | | Orion Pharma AG | | | | | | | | | | | | | 01.08. | | | | 01.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Stalevo 50/12.5/200 mg | Filmtabletten | Coated tablets (Entacapone 200 mg, Levodopa 50 mg, Carbidopa 12.5 mg) | N04BA03 | CI | | 02 | Stalevo 100/25/200 mg | Filmtabletten | Coated tablets (Entacapone 200 mg, Levodopa 100 mg, Carbidopa 25 mg) | N04BA03 | CI | | 03 | Stalevo 150/37.5/200 mg | Filmtabletten | Coated tablets (Entacapone 200 mg, Levodopa 150 mg, Carbidopa 37.5 mg) | N04BA03 | CI | | 04 | Stalevo 200/50/200 mg | Filmtabletten | Coated tablets (Entacapone 200 mg, Levodopa 200 mg, Carbidopa 50 mg) | N04BA03 | CI | | 05 | Stalevo 75/18.75/200 mg | Filmtabletten | Coated tablets (Entacapone 200 mg, Levodopa 75 mg, Carbidopa 18.75 mg) | N04BA03 | CI | | 06 | Stalevo 125/31.25/200 mg | Filmtabletten | Coated tablets (Entacapone 200 mg, Levodopa 125 mg, Carbidopa 31.25 mg) | N04BA03 | CI |
|
|
